The Cancer Genome Atlas Network (CGAN) identified p53 as being mutated in up to 96% of chemotherapy resistant, high-grade serous ovarian cancers, indicating an essential role for p53 mutations in serous ovarian cancer [6]. The gene discussed is TP53; the disease is ovarian serous adenocarcinoma.